Literature DB >> 3566377

Focal gastric mucosal blood flow in aspirin-induced ulceration.

T J Gana, R Huhlewych, J Koo.   

Abstract

Focal gastric mucosal blood flow was studied during aspirin injury by hydrogen gas clearance in a chambered segment model of canine gastric corpus. Measurements were made simultaneously every 15 minutes at ulcerated and nonulcerated areas 1.5 hours before, during (20 mM of aspirin in 150 mM of HCl for 1 hour), and 2 hours after exposure of the mucosa to topical aspirin. There was a highly significant decrease (p less than 0.001) in flow at the ulcerated areas 30 minutes after exposure to aspirin, coinciding with the appearance of focal mucosal pallor followed by subsequent hemorrhagic foci and ulceration. This was not followed by recovery to basal flow values. Blood flow to the non-ulcerated areas was significantly but less severely reduced than in the ulcerated areas (p less than 0.05) 90 minutes after exposure to aspirin. This was followed by recovery to basal levels. It is proposed that aspirin induces reduction of focal mucosal blood flow of varying degrees and that mucosal areas with flow reduced to below a "critical value" develop gross damage.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3566377      PMCID: PMC1492733          DOI: 10.1097/00000658-198704000-00010

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  16 in total

1.  EFFECTS OF GLYCINE AND OTHER INSTILLATES ON CONCENTRATION OF GASTRIC ACID.

Authors:  F G MOODY; R P DURBIN
Journal:  Am J Physiol       Date:  1965-07

2.  Acute gastric mucosal damage induced by bile salts, acid, and ischemia.

Authors:  W P Ritchie
Journal:  Gastroenterology       Date:  1975-04       Impact factor: 22.682

3.  Effect of aspirin, bile salt, and ethanol on canine gastric mucosal blood flow.

Authors:  L Y Cheung; F G Moody; R S Reese
Journal:  Surgery       Date:  1975-06       Impact factor: 3.982

4.  Effect of bile salts and aspirin on the gastric mucosal blood flow.

Authors:  P O'Brien; W Silen
Journal:  Gastroenterology       Date:  1973-02       Impact factor: 22.682

5.  Gastric mucosal blood flow following damage by ethanol, acetic acid, or aspirin.

Authors:  N A Augur
Journal:  Gastroenterology       Date:  1970-03       Impact factor: 22.682

6.  Focal gastric mucosal blood flow at the site of aspirin-induced ulceration.

Authors:  S W Ashley; L A Sonnenschein; L Y Cheung
Journal:  Am J Surg       Date:  1985-01       Impact factor: 2.565

7.  Contact electrode method in hydrogen gas clearance technique: a new method for determination of regional gastric mucosal blood flow in animals and humans.

Authors:  M Murakami; M Moriga; T Miyake; H Uchino
Journal:  Gastroenterology       Date:  1982-03       Impact factor: 22.682

8.  Drug-induced gastric mucosal injury.

Authors:  D Fromm
Journal:  World J Surg       Date:  1981-03       Impact factor: 3.352

9.  Measurements of gastric mucosal blood flow by hydrogen gas clearance.

Authors:  S W Ashley; L Y Cheung
Journal:  Am J Physiol       Date:  1984-10

10.  Regional gastric mucosal blood flow measurements by hydrogen gas clearance in the anesthetized rat and rabbit.

Authors:  F W Leung; P H Guth; O U Scremin; E M Golanska; G L Kauffman
Journal:  Gastroenterology       Date:  1984-07       Impact factor: 22.682

View more
  12 in total

1.  Sildenafil prevents indomethacin-induced gastropathy in rats: role of leukocyte adherence and gastric blood flow.

Authors:  Camila L Santos; Marcellus H L P Souza; Antoniella S Gomes; Henrique P Lemos; Armênio A Santos; Fernando Q Cunha; John L Wallace
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

Review 2.  Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives.

Authors:  F Halter; A S Tarnawski; A Schmassmann; B M Peskar
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

3.  Effect of allopurinol, sulphasalazine, and vitamin C on aspirin induced gastroduodenal injury in human volunteers.

Authors:  M E McAlindon; A F Muller; B Filipowicz; C J Hawkey
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

4.  Pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID gastropathy.

Authors:  P M Vaananen; C M Keenan; M B Grisham; J L Wallace
Journal:  Inflammation       Date:  1992-06       Impact factor: 4.092

5.  Intragastric accumulation of Evan's blue as a method for assessing aspirin-induced acute gastric mucosal injury in humans.

Authors:  K L Woods; J L Smith; D Y Graham
Journal:  Dig Dis Sci       Date:  1988-07       Impact factor: 3.199

6.  Gastric mucosal blood flow in misoprostol pretreated aspirin-induced ulceration.

Authors:  T J Gana; B R MacPherson; J Koo
Journal:  Ann Surg       Date:  1988-03       Impact factor: 12.969

7.  The CINOD, AZD3582, exhibits an improved gastrointestinal safety profile compared with naproxen in healthy volunteers.

Authors:  Bror Jonzon; Ingvar Bjarnason; Chris Hawkey; John Jones; Andrew Goddard; Urban Fagerholm; Pär Karlsson
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

8.  Role of gastric blood flow, neutrophil infiltration, and mucosal cell proliferation in gastric adaptation to aspirin in the rat.

Authors:  S J Konturek; T Brzozowski; J Stachura; A Dembinski; J Majka
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

9.  Effects and possible mechanisms of Alpinia officinarum ethanol extract on indomethacin-induced gastric injury in rats.

Authors:  Jingwen Gong; Zhong Zhang; Xuguang Zhang; Feng Chen; Yinfeng Tan; Hailong Li; Jie Jiang; Junqing Zhang
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

10.  Preventive effects of rebamipide on NSAID-induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers.

Authors:  Hyung-Keun Kim; Jin-Il Kim; Jae-Kwang Kim; Joon-Yeol Han; Soo-Heon Park; Kyu-Yong Choi; In-Sik Chung
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.